Is Ginkgo Bioworks Putting Its $1.5 Billion Cash Hoard to Good Use?
The synthetic biology leader's healthy cash balance provides plenty of breathing room, but it won't last forever.
The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global
Like